SCHEMBL20150488

SCHEMBL20150488

CCOC(=O)COc1ccccc1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
USP2 O75604 1/20 0.58
ABCB1 P08183 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
LMNA P02545 2/20 0.53
PTPN1 P18031 1/20 0.53
NPC1 O15118 1/20 0.53
S1PR4 O95977 1/20 0.53
MAPT P10636 1/20 0.53
ITGA4 P13612 1/20 0.53
HPGD P15428 1/20 0.53
S1PR1 P21453 1/20 0.53
MAPK1 P28482 1/20 0.53
RAB9A P51151 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TLR9 Q9NR96 1/20 0.53
F9 P00740 1/20 0.52
HSD17B10 Q99714 1/20 0.51
CASP3 P42574 1/20 0.51
CASP7 P55210 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2010417 0.88 USP2 (0.67) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL7335908 0.85 CYP1A2 (0.54) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL11825493 0.84 GLA (0.68) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL8871609 0.84 ALDH1A1 (0.56) ALDH1A1USP2SMN1; SMN2LMNAHSD17B10
SCHEMBL2871937 0.83 MAPT (0.62) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL2987183 0.83 CYP1A2 (0.58) ALDH1A1USP2HSD17B10CYP1A2CYP2C9
SCHEMBL15941407 0.81 F9 (0.51) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL3259595 0.81 USP2 (0.60) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL5318188 0.81 SMN1; SMN2 (0.64) ALDH1A1USP2ABCB1SMN1; SMN2LMNA
SCHEMBL3154126 0.81 L3MBTL1 (0.62) ALDH1A1USP2ABCB1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2021-07-29 US disclosed
US-20180134667-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ALDH1A1 171/4885USP2 1621/4885ABCB1 2660/4885
US-20180134667-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ALDH1A1 171/4885USP2 1621/4885ABCB1 2660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.